A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis

Acharyya, Swarnali, Oskarsson, Thordur, Vanharanta, Sakari, Malladi, Srinivas, Kim, Juliet, Morris, Patrick G., Manova-Todorova, Katia, Leversha, Margaret +5 more·2012·Cell

Cited by (1,000)

Items 101–200 of 1,000

  1. Yes-Associated Protein Mediates Immune Reprogramming in Pancreatic Ductal Adenocarcinoma
    S. Murakami, D. Shahbazian, R. Surana, Wei-Ying Zhang, Hengye Chen, G. Graham, Shannon M. White, L. Weiner, Chun-Ling Yi · 2016 · Oncogene
  2. Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications
    Jianwen Fang, Yue Lu, Jingyan Zheng, Xiaocong Jiang, Haixing Shen, Shang Xi, Yuexin Lu, Peifen Fu · 2023 · Cell Death and Disease
  3. The Role of CXC Chemokine Receptors 1–4 on Immune Cells in the Tumor Microenvironment
    Katharina Helene Susek, Maria Karvouni, Evren Alici, Andreas Lundqvist · 2018 · Frontiers in Immunology
  4. Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment
    Huy Q. Dinh, Feng Pan, Geng Wang, Qingfeng Huang, Claire E. Olingy, Zhi‐Yong Wu, Shaohong Wang, Xin Xu, Xiu‐E Xu, Jianzhong He et al. · 2021 · Nature Communications
  5. Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer
    Cameron N. Johnstone, Yvonne E. Smith, Yuan Cao, Allan D. Burrows, Ryan Stanley Cross, Xiawei Ling, Richard P. Redvers, Judy P. Doherty, Bedrich L. Eckhardt, Anthony L. Natoli et al. · 2015 · Disease Models & Mechanisms
  6. Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis
    Zhenghao Deng, Y Rong, Y Teng, X Zhuang, Abhilash Kumble Samykutty, J Mu, Luyao Zhang, Pengxiao Cao, Jun Yan, Donald Max Miller et al. · 2016 · Oncogene
  7. Neutrophil-activating therapy for the treatment of cancer
    Ian L. Linde, Tyler R. Prestwood, Jingtao Qiu, Genay O.W. Pilarowski, Miles Hamilton Linde, Xiangyue Zhang, Lei Shen, Nathan Edward Reticker-Flynn, David Kung‐Chun Chiu, Lauren Y. Sheu et al. · 2023 · Cancer Cell
  8. Metastatic-niche labelling reveals parenchymal cells with stem features
    Luigi Ombrato, Emma Nolan, Ivana Kurelac, Antranik Mavousian, Victoria Louise Bridgeman, Ivonne Heinze, Probir Chakravarty, Stuart D. Horswell, Estela González‐Gualda, Giulia Matacchione et al. · 2019 · Nature
  9. SASP: Tumor Suppressor or Promoter? Yes!
    Rao, Sonia G., Jackson, James G. · 2016 · Trends in Cancer
  10. Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC
    Junchao Cai, Lishan Fang, Yongbo Huang, Rong Li, Xiaonan Xu, Zhihuang Hu, Le Zhang, Yi Yang, Xun Zhu, Heng Zhang et al. · 2017 · Nature Communications
  11. Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer
    Pyong‐Gon Moon, Jeong‐Eun Lee, Young‐Eun Cho, Soo Jung Lee, Yee Soo Chae, Jin Hyang Jung, In-San Kim, Ho Yong Park, Moon‐Chang Baek · 2016 · Oncotarget
  12. Targeting the tumour vasculature: from vessel destruction to promotion
    Sophie Guelfi, Kairbaan Hodivala‐Dilke, Gabriele Bergers · 2024 · Nature reviews. Cancer
  13. Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle
    Wang, Gang, Biswas, Anup K., Ma, Wanchao, Kandpal, Manoj, Coker, Courtney, Grandgenett, Paul M., Hollingsworth, Michael A., Jain, Rinku, Tanji, Kurenai, Lόpez-Pintado, Sara et al. · 2018 · Nature Medicine
  14. Inflammation amplifier, a new paradigm in cancer biology
    Atsumi, Toru, Singh, Rajeev, Sabharwal, Lavannya, Bando, Hidenori, Meng, Jie, Arima, Yasunobu, Yamada, Moe, Harada, Masaya, Jiang, Jing-Jing, Kamimura, Daisuke et al. · 2014 · Cancer Research
  15. A nineteen gene‐based risk score classifier predicts prognosis of colorectal cancer patients
    Seon‐Young Kim, Seon‐Young Kim, Jeong‐Hwan Kim, Seon Ae Roh, Dong‐Hyung Cho, Seon‐Young Kim, Jin Cheon Kim · 2014 · Molecular Oncology
  16. PI3K/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells
    Amirhosein Maharati, Meysam Moghbeli · 2023 · Cell Communication and Signaling
  17. Neutrophils in the Tumor Microenvironment
    Lingyun Wu, Sugandha Saxena, Rakesh K. Singh · 2020 · Advances in experimental medicine and biology
  18. Tenascin C in metastasis: A view from the invasive front
    Lowy, Camille M, Oskarsson, Thordur · 2015 · Cell Adhesion & Migration
  19. Targeting NF-κB signaling pathway in cancer by dietary polyphenols
    Haroon Zaman Khan, Hammad Ullah, Paula C. Castilho, Antoni Sureda, Grazia D’Onofrio, Rosanna Filosa, Fang Wang, Seyed Mohammad Nabavi, Maria Daglia, Ana T. Sanches-Silva et al. · 2019 · Critical Reviews in Food Science and Nutrition
  20. Tumor Microenvironment in Breast Cancer—Updates on Therapeutic Implications and Pathologic Assessment
    Joshua Jing Xi Li, Julia Y. Tsang, Gary Man-Kit Tse · 2021 · Cancers
  21. Emerging targeted agents in metastatic breast cancer
    Dimitrios Zardavas, Jose M Baselga, Martine J Piccart · 2013 · Nature Reviews Clinical Oncology
  22. Tumor Microenvironment Heterogeneity: Challenges and Opportunities
    Farhana Runa, Sarkis Hamalian, Kayla Meade, Preston Shisgal, Peter Clarke Gray, Jonathan A. Kelber · 2017 · Current Molecular Biology Reports
  23. Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors
    Magdolna Djurec, Osvaldo Graña‐Castro, Albert Lee, Kevin Troulé, Elisa Espinet, Lavinia Cabras, Carolina Navas, María Teresa Blasco, Laura Martín-Díaz, Miranda Burdiel et al. · 2018 · Proceedings of the National Academy of Sciences
  24. Myeloid‐derived suppressor cells: Important contributors to tumor progression and metastasis
    Elham Safarzadeh, Mona Orangi, Hamed Mohammadi, Farhad Babaie, Behzad Baradaran · 2017 · Journal of Cellular Physiology
  25. Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis
    Christiana Michael Neophytou, Panagiotis Boutsikos, Panagiotis Papageorgis · 2018 · Frontiers in Oncology
  26. MLKL in cancer: more than a necroptosis regulator
    Sofie Martens, Jolien Bridelance, Ria Roelandt, Peter Vandenabeele, Nozomi Takahashi · 2021 · Cell Death and Differentiation
  27. NF-κB and STAT1 control CXCL1 and CXCL2 gene transcription
    Susan J. Burke, Danhong Lu, Tim E. Sparer, Thomas J. Masi, Matthew Ray Goff, Michael D. Karlstad, J. Jason Collier · 2013 · American Journal of Physiology-Endocrinology and Metabolism
  28. Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms
    Marco Bezzi, Nina Seitzer, Tomoki Ishikawa, Markus Reschke, Ming Chen, Guocan Wang, Caitlin Mitchell, Christopher Ng, Jesse Mae Katon, Andrea Lunardi et al. · 2018 · Nature Medicine
  29. Mechanisms of the Epithelial–Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer
    Jacek Baj, Izabela Korona‐Głowniak, Alicja Forma, Amr Maani, Ryszard Sitarz, Mansur Rahnama, Elżbieta Radzikowska, Piero Portincasa · 2020 · Cells
  30. CD146, from a melanoma cell adhesion molecule to a signaling receptor
    Zhaoqing Wang, Qingji Xu, Nengwei Zhang, Xuemei Du, Guangzhong Xu, Xiyun Yan · 2020 · Signal Transduction and Targeted Therapy
  31. The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment
    Yanghong Ni, Xiaoting Zhou, Jia Yang, Houhui Shi, Hongyi Li, Xia Zhao, Xuelei Ma · 2021 · Frontiers in Cell and Developmental Biology
  32. NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma
    Wilson, C. L., Jurk, D., Fullard, N., Banks, P., Page, A., Luli, S., Elsharkawy, A. M., Gieling, R. G., Chakraborty, J. Bagchi, Fox, C. et al. · 2015 · Nature Communications
  33. Metastatic niche functions and therapeutic opportunities
    Toni Celià-Terrassa, Yibin Kang · 2018 · Nature Cell Biology
  34. Nanomedicine‐Based Immunotherapy for the Treatment of Cancer Metastasis
    Pengcheng Zhang, Yihui Zhai, Ying Cai, Yuliang Zhao, Yaping Li · 2019 · Advanced Materials
  35. IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
    Zhen Ning Wee, Siti Maryam J. M. Yatim, Vera Kohlbauer, Min Feng, Jian Yuan Goh, Yi Bao, Puay Leng Lee, Songjing Zhang, Pan Pan Wang, Elgene Lim et al. · 2015 · Nature Communications
  36. Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response
    Camilla Salvagno, Metamia Ciampricotti, Sander Tuit, Cheei‐Sing Hau, Antoinette van Weverwijk, Seth B. Coffelt, Kelly Kersten, Kim Vrijland, Kevin Kos, Thomas Ulas et al. · 2019 · Nature Cell Biology
  37. CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer
    Jan Korbecki, Patrycja Kupnicka, Mikołaj Chlubek, Jarosław Gorący, Izabela Gutowska, Irena Baranowska‐Bosiacka · 2022 · International Journal of Molecular Sciences
  38. ISG15 Is a Critical Microenvironmental Factor for Pancreatic Cancer Stem Cells
    Bruno Sáinz, Beatriz Martín, Marianthi N. Tatari, Christopher Heeschen, Susana Guerra · 2014 · Cancer Research
  39. TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer
    Sandeep Rajput, Lisa D. Volk-Draper, Sophia Ran · 2013 · Molecular Cancer Therapeutics
  40. RAS–Mitogen-Activated Protein Kinase Signal Is Required for Enhanced PD-L1 Expression in Human Lung Cancers
    Hidetoshi Sumimoto, Atsushi Takano, Koji Teramoto, Yataro Daigo · 2016 · PLoS ONE
  41. Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
    Tavora, Bernardo, Reynolds, Louise E., Batista, Silvia, Demircioglu, Fevzi, Fernandez, Isabelle, Lechertier, Tanguy, Lees, Delphine M., Wong, Ping-Pui, Alexopoulou, Annika, Elia, George et al. · 2014 · Nature
  42. CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment
    Tao Zhang, Chieh Tseng, Yan Zhang, Olga Sirin, Paul Gettys Corn, Elsa M. Li-Ning-Tapia, Patricia Troncoso, John Warren Davis, Curtis Alvin Pettaway, John Francis Ward et al. · 2016 · Nature Communications
  43. Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer
    Aimalie Hardaway, Mackenzie K. Herroon, Erandi N. Rajagurubandara, Izabela Podgorski · 2015 · Clinical & Experimental Metastasis
  44. Targeting IL-17B–IL-17RB signaling with an anti–IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines
    Heng‐Hsiung Wu, Wendy W. Hwang‐Verslues, Wen-Hsin Lee, Chun-Kai Huang, Pei‐Chi Wei, Chia-Lin Chen, Jin‐Yuh Shew, Eva Y.-H.P. Lee, Yung‐Ming Jeng, Yu‐Wen Tien et al. · 2015 · The Journal of Experimental Medicine
  45. A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model
    Keunhee Oh, Ok-Young Lee, Suh-Youn Shon, Onyou Nam, P. Ryu, M. Seo, Dong-Sup Lee · 2013 · Breast Cancer Research
  46. Carcinoma-Associated Fibroblasts Are a Promising Therapeutic Target
    Shinsaku Togo, Urszula M. Polanska, Yoshiya Horimoto, Akira Orimo · 2013 · Cancers
  47. Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization
    Elisabetta Marcuzzi, Roberta Angioni, Barbara Molon, Bianca Calì · 2018 · International Journal of Molecular Sciences
  48. TNF-α/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells
    Hiroko Oshima, T Ishikawa, Go J. Yoshida, Kuniko Naoi, Y Maeda, Kazuhito Naka, X Ju, Yoichi M. A. Yamada, Toshinari Minamoto, Naofumi Mukaida et al. · 2013 · Oncogene
  49. CXCL1: Gene, Promoter, Regulation of Expression, mRNA Stability, Regulation of Activity in the Intercellular Space
    Jan Korbecki, Katarzyna Barczak, Izabela Gutowska, Dariusz Chlubek, Irena Baranowska‐Bosiacka · 2022 · International Journal of Molecular Sciences
  50. From sentinel cells to inflammatory culprits: cancer‐associated fibroblasts in tumour‐related inflammation
    Charlotte Servais, Neta Erez · 2012 · The Journal of Pathology
  51. Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction
    Paul C. McDonald, Shawn C. Chafe, Shoukat Dedhar · 2016 · Frontiers in Cell and Developmental Biology
  52. CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells
    Margaret Gil, Marcin P. Komorowski, Mukund Seshadri, Hanna Rokita, AJ Robert McGray, Mateusz Opyrchal, Kunle O. Odunsi, Danuta Kozbor · 2014 · The Journal of Immunology
  53. IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis
    Yu Zhang, Celestia Davis, Sapana N. Shah, Daniel Titus Hughes, James C. Ryan, Diego Altomare, Maria Marjorette O. Peña · 2016 · Molecular Carcinogenesis
  54. The lack of type I interferon induces neutrophil-mediated pre-metastatic niche formation in the mouse lung
    Ching‐Fang Wu, Lisa Andzinski, Nadine Kasnitz, Andrea Kröger, Frank Klawonn, Stefan Lienenklaus, Siegfried Weiß, Jadwiga Jabłońska · 2015 · International Journal of Cancer
  55. The CXCL5/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis
    Ricardo Romero-Moreno, Kimberly J. Curtis, Thomas R. Coughlin, María Cristina Miranda-Vergara, Shourik Dutta, Aishwarya Natarajan, Beth A. Facchine, Kristen M. Jackson, Lukas M. Nystrom, Jun Li et al. · 2019 · Nature Communications
  56. Transmembrane (TMEM) protein family members: Poorly characterized even if essential for the metastatic process
    Sébastien Marx, Thomas Dal Maso, Jia-Wei Chen, Marina Bury, Johan Wouters, Carine Michiels, Benjamin Le Calvé · 2019 · Seminars in Cancer Biology
  57. Cancer-associated fibroblasts: how do they contribute to metastasis?
    Mei Qi Kwa, Kate Møller Herum, Cord Brakebusch · 2019 · Clinical & Experimental Metastasis
  58. Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells
    A. Poh, R. O'Donoghue, M. Ernst · 2015 · OncoTarget
  59. CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma
    Longzi Liu, Zhao Zhang, Bo‐Hao Zheng, Yang Shi, Men Duan, Lijie Ma, Zhichao Wang, Liangqing Dong, Ping‐Ping Dong, Jie-Yi Shi et al. · 2018 · Hepatology
  60. Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling
    Barath Udayasuryan, Raffae N. Ahmad, Tam T. D. Nguyen, Ariana Umaña, LaDeidra Monét Roberts, Polina Sobol, Stephen D. Jones, Jennifer M. Munson, Daniel Joseph Slade, Scott S. Verbridge · 2022 · Science Signaling
  61. Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment
    Bruno Sáinz, Sonia Alcalá, Elena García, Yolanda Sanchez-Ripoll, Maria M. Azevedo, Michele Cioffi, Marianthi N. Tatari, Irene Miranda‐Lorenzo, Manuel M. Hidalgo, Gonzalo Goméz-López et al. · 2015 · Gut
  62. Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer
    Laura M. Campbell, Pamela J. Maxwell, David J J Waugh · 2013 · Pharmaceuticals
  63. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8–CXCR2 Axis
    Ryotaro Ogawa, Takamasa S. Yamamoto, Hideyo Hirai, Keita Hanada, Yoshiyuki Kiyasu, Gen Nishikawa, Rei Mizuno, Susumu Inamoto, Yoshiro Itatani, Yoshiharu Sakai et al. · 2019 · Clinical Cancer Research
  64. CDK8/19 Mediator kinases potentiate induction of transcription by NFκB
    Mengqian Chen, Jiaxin Liang, Hao Ji, Zhengguan Yang, Serena Altilia, Bing Hu, Adam Schronce, Martina S.J. McDermott, Gary P. Schools, Chang‐Uk Lim et al. · 2017 · Proceedings of the National Academy of Sciences
  65. Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone
    Hernan Roca, Jacqueline Jones, Marta C. Purica, Savannah Weidner, Amy J. Koh, Robert Kuo, John Erby Wilkinson, Yugang Wang, Stephanie Daignault‐Newton, Kenneth J. Pienta et al. · 2017 · Journal of Clinical Investigation
  66. Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment
    Sundary Sormendi, Ben Wielockx · 2018 · Frontiers in Immunology
  67. CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression
    Meiling Zhang, Zongzhi Z. Liu, Keisuke Aoshima, Wesley L. Cai, Hongyin Sun, Tianrui Xu, Yangyi Zhang, Yongyan An, Jocelyn Fang-Yi Chen, Lok-Hei Chan et al. · 2022 · Science Translational Medicine
  68. Mechanisms of resistance to anti-angiogenesis therapies
    Sandy Giuliano, Gilles Pagès · 2013 · Biochimie
  69. Immune-mediated mechanisms influencing the efficacy of anticancer therapies
    Seth B. Coffelt, Karin E. de Visser · 2015 · Trends in Immunology
  70. Tumor microenvironment-mediated chemoresistance in breast cancer
    Kobra Velaei, Nasser Samadi, Balal Brazvan, Jafar Soleimani Rad · 2016 · The Breast
  71. Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway
    Vicenç Ruiz de Porras, Sara Bystrup, Anna Martínez‐Cardús, Raquel Pluvinet, Lauro Sumoy, Lynne M. Howells, Mark I. James, Chinenye Iwuji, José Luís Manzano, Laura Layos et al. · 2016 · Scientific Reports
  72. Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations
    Charlotte R. Bell, Victoria S. Pelly, Agrin Moeini, Shih‐Chieh Chiang, Eimear Flanagan, Christian P. Bromley, C I Clark, Charles H. Earnshaw, Maria A. Koufaki, Eduardo Bonavita et al. · 2022 · Nature Communications
  73. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy
    Dina Morein, Nofar Erlichman, Adit Ben‐Baruch · 2020 · Frontiers in Immunology
  74. Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis
    Nishida, Jun, Momoi, Yusaku, Miyakuni, Kosuke, Tamura, Yusuke, Takahashi, Kei, Koinuma, Daizo, Miyazono, Kohei, Ehata, Shogo · 2020 · Nature Cell Biology
  75. Chronic inflammation and cancer; the two sides of a coin
    Queenie Fernandes, Varghese Philipose Inchakalody, Takwa Bedhiafi, Sarra Mestiri, Nassiba Taib, Shahab Uddin M.S., Maysaloun Merhi, Said Dermime · 2023 · Life Sciences
  76. BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer
    Ashkan Shahbandi, Sonia G. Rao, Ashlyn Y. Anderson, Wesley D. Frey, Joy O. Olayiwola, Nathan Ungerleider, James G. Jackson · 2020 · Cell Death and Differentiation
  77. The tumor microenvironment controls drug sensitivity
    Arne Östman · 2012 · Nature Medicine
  78. Targeting tumor–stromal interactions in bone metastasis
    Mark Esposito, Yibin Kang · 2013 · Pharmacology & Therapeutics
  79. Cancer stem cells and their unique role in metastatic spread
    Teresa Bernadette Steinbichler, Dragana Savic, József Dudás, Irma Kvitsaridze, Sergej Skvortsov, Herbert Riechelmann, Ira Skvortsova · 2019 · Seminars in Cancer Biology
  80. Neutrophil dynamics in the tumor microenvironment
    Amanda J. McFarlane, Frédéric Fercoq, Seth B. Coffelt, Leo M. Carlin · 2021 · Journal of Clinical Investigation
  81. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities
    Umar Mehraj, Rais A. Ganai, Muzafar Ahmad Macha, Abid Hamid, Mohammed A. Zargar, Ajaz Ahmad Bhat, Mohd Wasim Nasser, Mohammad Haris, Surinder K. Batra, Bader Alshehri et al. · 2021 · Cellular Oncology
  82. Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme
    Jiemiao Hu, Qingnan Zhao, Ling-Yuan Kong, Jian Wang, Jun Yan, Xueqing Xia, Zhiliang Jia, Amy B. Heimberger, Shulin Li · 2021 · Science Advances
  83. Harnessing the chemokine system to home CAR-T cells into solid tumors
    Jade Foeng, Iain Comerford, Shaun R. McColl · 2022 · Cell Reports Medicine
  84. Awakened by Cellular Stress: Isolation and Characterization of a Novel Population of Pluripotent Stem Cells Derived from Human Adipose Tissue
    Saleh G. Heneidi, Ariel A. Simerman, E. Keller, Prapti Singh, Xinmin Li, Daniel Anthony Dumesic, Gregorio Daniel Chazenbalk · 2013 · PLoS ONE
  85. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer
    Sara Cabrero‐de las Heras, Eva Martinez‐Balibrea · 2018 · World Journal of Gastroenterology
  86. A C-X-C Chemokine Receptor Type 2–Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis
    Zhijun Zhou, Guanggai Xia, Zhen Xiang, Mingyang Liu, Zhewei Wei, Jie Yan, Wei Chen, Jintao Zhu, Niranjan Awasthi, Xiaotian Sun et al. · 2019 · Clinical Cancer Research
  87. Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance
    Fei Chen, Qilai Long, Da Fu, Dexiang Zhu, Yan Ji, Liu Han, Boyi Zhang, Qixia Xu, Bingjie Liu, Yan Li et al. · 2018 · Nature Communications
  88. Systematic screen of chemotherapeutics in Drosophila stem cell tumors
    Michele Markstein, Samantha Dettorre, Julio Cho, Ralph A. Neumüller, Soren Craig-Muller, Norbert Perrimon · 2014 · Proceedings of the National Academy of Sciences
  89. Cancer Metastasis: A Reappraisal of Its Underlying Mechanisms and Their Relevance to Treatment
    Nicolò Riggi, Michel Aguet, Ivan Stamenkovic · 2017 · Annual Review of Pathology Mechanisms of Disease
  90. Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
    Martina Musella, Andrea Guarracino, Nicoletta Manduca, Claudia Galassi, Eliana Ruggiero, Alessia Potenza, Ester Maccafeo, Gwenola Manic, Luca Mattiello, Sara Soliman Abdel Rehim et al. · 2022 · Nature Immunology
  91. Chemotherapy-Induced Metastasis: Molecular Mechanisms, Clinical Manifestations, Therapeutic Interventions
    George S. Karagiannis, John S. Condeelis, Maja H. Oktay · 2019 · Cancer Research
  92. H3K18 lactylation-mediated VCAM1 expression promotes gastric cancer progression and metastasis via AKT-mTOR-CXCL1 axis
    Yupeng Zhao, Jiang Jiang, Peng Zhou, Kaiyuan Deng, Ziyuan Liu, Mengqi Yang, Xiao Yang, Jianfang Li, Ranran Li, Jiazeng Xia · 2024 · Biochemical Pharmacology
  93. A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer
    Elin Sjöberg, Max Meyrath, Laura Milde, Mercedes Herrera, John Lövrot, Daniel Hägerstrand, Oliver Frings, Margarita Bartish, Charlotte Rolny, Erik L. L. Sonnhammer et al. · 2019 · Clinical Cancer Research
  94. miR141–CXCL1–CXCR2 Signaling–Induced Treg Recruitment Regulates Metastases and Survival of Non–Small Cell Lung Cancer
    Mingming Lv, Yujun Xu, Ruijing Tang, Jing Ren, Sunan Shen, Yueqiu Chen, Baorui Liu, Yayi Hou, Tingting Wang · 2014 · Molecular Cancer Therapeutics
  95. Pretreatment with probiotic Bifico ameliorates colitis‐associated cancer in mice: Transcriptome and gut flora profiling
    Huan Song, Weiyi Wang, Bo Shen, Hao Jia, Zhaoyuan Hou, Ping Chen, Yunwei Sun · 2017 · Cancer Science
  96. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases
    Sébastien Tabariès, Véronique Ouellet, Brian E. Hsu, Matthew G. Annis, April A. N. Rose, Liliane Meunier, Eurı́dice Carmona, Christine Tam, Anne‐Marie Mes‐Masson, Peter M. Siegel · 2015 · Breast Cancer Research
  97. Modelling the tumour microenvironment in long-term microencapsulated 3D co-cultures recapitulates phenotypic features of disease progression
    Marta F Estrada, Sofia P. Rebelo, Emma Jane Davies, Marta Teixeira Pinto, Hugo Pereira, Vítor Espirito Santo, Matthew John Smalley, Simon T. Barry, Emilio J. Gualda, Paula M. Alves et al. · 2015 · Biomaterials
  98. Cancer extracellular vesicles contribute to stromal heterogeneity by inducing chemokines in cancer-associated fibroblasts
    Yutaka Naito, Yusuke Yamamoto, Naoya Sakamoto, Iwao Shimomura, Akiko Kogure, Minami Kumazaki, Akira Yokoi, Masakazu Yashiro, Tohru Kiyono, Kazuyoshi Yanagihara et al. · 2019 · Oncogene
  99. Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes
    Amy W. Ku, Jason B. Muhitch, Colin A. Powers, Michael R. Diehl, Minhyung Kim, Daniel T. Fisher, Anand P. Sharda, Virginia K. Clements, Kieran L. O’Loughlin, Hans Minderman et al. · 2016 · eLife
  100. Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights into Stromal-Mediated Radioresistance
    Varintra E. Krisnawan, Jennifer Anne Stanley, Julie Kristina Schwarz, David G. DeNardo · 2020 · Cancers